Severe hypertriglyceridemia and pancreatitis: presentation and management
The DOI matches its Crossref record; 83 of the 84 references it cites were found in a registry or an index.
Abstract
Purpose of review Hypertriglyceridemia (HTG) is a well recognized cause of acute pancreatitis accounting for approximately up to 10% of all cases and even up to 50% of all cases in pregnancy. Both primary and secondary disorders of lipoprotein metabolism may be associated with hypertriglyceridemic pancreatitis (HTGP). The purpose of this review is to provide an overview of the current studies on presentation and management of HTGP. Recent findings/conclusion Hydrolysis of triglycerides by pancreatic lipase and formation of free fatty acids that induce inflammatory changes are postulated to account for the development of HTGP, yet the exact pathophysiology remains unclear. The clinical features of patients with HTGP are generally not different from patients with acute pancreatitis of other causes, and there is some evidence that HTGP is associated with a higher severity or a higher complication rate. There is no clear evidence as to which HTG patients will develop pancreatitis. Several studies have evaluated the effect of apheresis, the benefit of insulin and/or heparin treatment and the use of different antihyperlipidemic agents in HTGP. Dietary modifications resemble the key features in the long-term management of HTG. Whether HTG may cause chronic pancreatitis in the long-term follow-up remains controversial.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Such an approach has been recommended by the National Lipid Association 10 and International Atherosclerosis Society 117 for patients with HTG or VHTG.”
From Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association (2019) · cites this paper as [10]
In the citing paper
“In the acute setting apheresis is able to lower TG levels rapidly.123”
From ESC/EAS Guidelines for the management of dyslipidaemias (2011) · cites this paper as [123]
In the citing paper
“In the acute setting, plasmapheresis is able to rapidly lower TG levels. 308”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [308]
In the citing paper
“Overall, alcohol abuse and gallstone disease account for at least 80% of all cases of acute pancreatitis, with hypertriglyceridemia contributing Ϸ10% of cases.105,134”
From Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association (2011) · cites this paper as [105]
In the citing paper
“Because documentation for a specific threshold in triglyceride-induced pancreatitis is lacking, levels associated with increased risk are arbitrarily defined as triglyceride levels Ն1000 mg/dL”
From Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association (2011) · cites this paper as [105]
Citations
Cites
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Mechanism of Action of Fibrates on Lipid and Lipoprotein Metabolism
Staels, B., Dallongeville, J., Auwerx, J., Schoonjans, K., Leitersdorf, E., & Fruchart, J.-C. (1998) · Circulation · doi:10.1161/01.cir.98.19.2088 · Cited by 1,786
PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect
Tunaru, S., Kero, J., Schaub, A., Wufka, C., Blaukat, A., Pfeffer, K., & Offermanns, S. (2003) · Nature Medicine · doi:10.1038/nm824 · Cited by 791
Molecular Identification of High and Low Affinity Receptors for Nicotinic Acid
Wise, A., Foord, S. M., Fraser, N. J., Barnes, A. A., Elshourbagy, N., Eilert, M., Ignar, D. M., Murdock, P. R., Steplewski, K., Green, A., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210695200 · Cited by 539
Issues in Hyperlipidemic Pancreatitis
Yadav, D., & Pitchumoni, C. S. (2003) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200301000-00016 · Cited by 435
(1995) · PubMed · Cited by 423
Safety considerations with fibrate therapy
Davidson, M. H., Armani, A., McKenney, J. M., & Jacobson, T. A. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.11.016 · Cited by 408
Hypertriglyceridemic Pancreatitis: Presentation and Management
Tsuang, W., Navaneethan, U., Ruiz, L., Palascak, J. B., & Gelrud, A. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.27 · Cited by 395
Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin
Jones, P. H., & Davidson, M. H. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.08.076 · Cited by 387
Research works printed but not linked: 1
- Speck, 1865, A case of lipidemia., Arch Verin Wissenschaftl Heilkunde, 1, 232
Cited by
Items 101–200 of 274
Update on the management of severe hypertriglyceridemia – focus on free fatty acid forms of omega-3
Catapano, A. L., & Pirillo, A. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s67551 · Cited by 36
“3 mmol/L) significantly increased the risk of pancreatitis, but more moderate increases of TG (177–885 mg/dL, 2–10 mmol/L) may be usually present during the early phases of acute pancreatitis.(14) Several studies have also observed that the severity of pancreatitis is higher in subjects with HTG-induced pancreatitis c…”
BackgroundYin, G., Hu, G., Cang, X., Yu, G., Hu, Y., Xing, M., Chen, C., Huang, Y., Tang, M., Zhao, Y. F., et al. (2014) · Pancreas · doi:10.1097/mpa.0000000000000187 · Cited by 23
Kang, J. S., Lee, W. K., Yoon, W. K., Kim, N., Park, S. Y., Park, H. K., Ly, S. Y., Han, S., Yun, J., Lee, C. W., et al. (2011) · Phytotherapy Research · doi:10.1002/ptr.3476 · Cited by 22
“© 2011 John Wiley & Sons, Ltd. presence of raised levels of any or all lipids and/or lipoproteins in the blood and causes serious health problems, including atherosclerosis and acute pancreatitis (Ewald et al., 2009).”
BackgroundDing, N., Guo, C., Song, K., Li, C., Zhou, Y., Yang, G., & Chai, X. (2021) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2021.08.009 · Cited by 21
Ancestry-specific profiles of genetic determinants of severe hypertriglyceridemia
Gill, P. K., Dron, J. S., Dilliott, A. A., McIntyre, A. D., Cao, H., Wang, J., Movsesyan, I., Malloy, M. J., Pullinger, C. R., Kane, J. P., et al. (2020) · Journal of clinical lipidology · doi:10.1016/j.jacl.2020.11.007 · Cited by 22
High Triglyceride Variability Increases the Risk of First Attack of Acute Pancreatitis
Tung, Y., Hsiao, F., Lin, C., Ho, C.-T., Hsu, T., Chiang, H., & Chu, P. (2022) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002198 · Cited by 20
“Another hypothesis is chylomicronemia-inducedhyperviscosity inpancreatic capillaries, leading to subsequent ischemia, tissue necrosis, and inflammation in the pancreas (8,9).”
BackgroundSevere acute pancreatitis due to tamoxifen-induced hypertriglyceridemia with diabetes mellitus.
Kim, Y. A., Lee, S., Jung, J. W., Kwon, Y., Lee, G. B., Shin, D. G., Park, S. S., Yun, J., Jang, Y.-S., & Cho, D. H. (2014) · Chinese Journal of Cancer Research · doi:10.3978/j.issn.1000-9604.2014.05.01 · Cited by 20
“Moreover, the degradation of triglycerides to free fatty acids by pancreatic lipases may lead to further cytotoxic injuries, which increase inflammatory mediators that may result in aggravation of the pancreatitis (8).”
BackgroundHammond, D. A., & Finlay, L. (2017) · Hospital Pharmacy · doi:10.1177/0018578717725168 · Cited by 20
“This is especially true with regard to hypertriglyceridemia, as this etiology may cause more severe acute pancreatitis and worse symptoms than other causes of the disease.(1,4,5) Mechanisms for hypertriglyceridemia-induced acute pancreatitis (HTGP) development have been postulated.”
BackgroundGhoor, S., Berlyn, P., & Brey, N. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.10.018 · Cited by 19
Hypertriglyceridemic Pancreatitis: Is Insulin Monotherapy A Feasible Therapeutic Option?
Inayat, F., Zafar, F., Riaz, I., Younus, F., Baig, A. S., & Imran, Z. (2018) · Cureus · doi:10.7759/cureus.3461 · Cited by 19
Propofol Infusion and Acute Pancreatitis: A Review
Asghar, M. U., Cheema, H. A., Tanveer, K., & Leinwand, J. (2019) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001021 · Cited by 19
Susceptibility Factors and Cellular Mechanisms Underlying Alcoholic Pancreatitis
Takahashi, T., Miao, Y., Kang, F., Dolai, S., & Gaisano, H. Y. (2020) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14304 · Cited by 19
Acute pancreatitis owing to very high triglyceride levels treated with insulin and heparin infusion
Aryal, M. R., Mainali, N. R., Gupta, S., & Singla, M. (2013) · BMJ Case Reports · doi:10.1136/bcr-2013-008550 · Cited by 19
“10 In summary, after reviewing the available literature and analysing the outcomes of our own case, the most reasonable approach for managing patients admitted to an acute care facility for acute pancreatitis due to very high (greater than 1000 mg/dl) TG levels consists of dietary restrictions, fl…”
Hypertriglyceridemic pancreatitis
de Pretis, N., Marchi, G. D., & Frulloni, L. (2020) · Minerva Gastroenterologica e Dietologica · doi:10.23736/s1121-421x.19.02641-2 · Cited by 18
Wu, H., Ma, K., Liao, B., Ji, T., Zhang, S., & Cao, T. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3771610 · Cited by 18
“Several clinical researches [3, 48 – 50] indicated that from the comparison of severity and complications between di ff erent types of AP, hypertriglyceridemic AP had higher rate of complication incidences and mortality than other types of AP; this was highly in coincidence with the results of our…”
RetractedAcute pancreatitis caused by hypertriglyceridemia
Baranyai, T., Terzin, V., Vajda, Á., Wittmann, T., & Czakó, L. (2010) · Orvosi Hetilap · doi:10.1556/oh.2010.28966 · Cited by 18
Lashkari, H. P., Lancaster, D., Atra, A., Champion, M. P., & Taj, M. (2011) · International Journal of Hematology · doi:10.1007/s12185-011-0966-9 · Cited by 18
“However, there is no consensus in the management of hypertriglyceridaemia [19].”
BackgroundPedragosa, À., Merino, J., Aranda, J. L., Galiana, J., Godoy, D., Panisello, J. M., Ascaso, J. F., Civeira, F., Masana, L., & Pedro‐Botet, J. (2012) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2012.11.001 · Cited by 16
Yang, N., Zhang, D., Hao, J., & Wang, G. (2016) · Journal of International Medical Research · doi:10.1177/0300060515618052 · Cited by 16
“FFAs can directly damage pancreatic acinar cells and significantly inhibit the protein binding, deiodination and conversion of THs.(9,44) 274 Journal of International Medical Research 44(2)”
BackgroundInfluentialStatin Use in Patients With Acute Pancreatitis and Symptomatic Gallstone Disease
Pulkkinen, J., Kastarinen, H., Kiviniemi, V. V., Jyrkkä, J., Juvonen, P., Räty, S., & Paajanen, H. (2014) · Pancreas · doi:10.1097/mpa.0000000000000068 · Cited by 17
“Hypertriglyceridemia is 1 common cause of pancreatitis in many countries, and it can be treated successfully by statin therapy.(18,23) In animal models, statins have decreased the inflammatory mediators released during AP (interleukin [IL] 1A, IL-6, and tumor necrosis factor >).”
BackgroundTamoxifen Induced Pancreatitis: An Unusual Complication of Commonly used Drug
Kataria, P., Kendre, P., Patel, A., Bohra, M., & Tahiliani, N. (2017) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2017/27440.10467 · Cited by 16
Primary Hypertriglyceridemia: A Look Back on the Clinical Classification and Genetics of the Disease
Musambil, M., Al-Rubeaan, K. A., Al-Qasim, S., Alnaqeb, D., & Al-Soghayer, A. (2020) · Current Diabetes Reviews · doi:10.2174/1573399815666190502164131 · Cited by 16
de Souza, M. D. M., Mendes, B. X., Defante, M. L. R., Morais, B. A. D. A. D. H., Martins, O. C., Prizão, V. M., & Romaniello, G. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156187 · Cited by 16
Hovland, A., Hardersen, R. I., Mollnes, T. E., & Lappegård, K. T. (2015) · PubMed · doi:10.6092/1590-8577/3437 · Cited by 15
“Several mechanisms for the disease have been proposed, including the hydrolysis of triglycerides forming free fatty acids inducing inflammation, chylomicrons inducing hyperviscosity leading to ischemia, and finally genetic predisposition [2, 3].”
BackgroundSevere acquired hypertriglyceridemia following COVID-19
Fijen, L. M., Grefhorst, A., Levels, J. H. M., & Cohn, D. M. (2021) · BMJ Case Reports · doi:10.1136/bcr-2021-246698 · Cited by 15
“18 If a patient develops severe hypertriglyceridemia following COVID-19, the diagnosis of acquired LPL deficiency should be considered.”
BackgroundHe, S.-S., Li, D., He, Q., Chen, X., Lin, Y., Yu, Y.-W., Chen, F., & Ding, J. D. (2022) · Gastroenterology Research and Practice · doi:10.1155/2022/5142473 · Cited by 15
de Castro-Orós, I., Civeira, F., Pueyo, M. J., Mateo‐Gállego, R., Bolado‐Carrancio, A., Lamíquiz-Moneo, I., Álvarez-Sala, L., Romero, F. F., Cofán, M., Cenarro, A., et al. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2016.02.010 · Cited by 15
“People with this condition are homozygous or compound heterozygous for lost-of-function mutations in LPL, APOC2, LMF1, APOA5, and GPIHBP1 (3,7,8).”
BackgroundClinical Course of Diabetic Ketoacidosis in Hypertriglyceridemic Pancreatitis
Quintanilla-Flores, D. L., Rendón-Ramírez, E. J., Colunga-Pedraza, P. R., Gallardo-Escamilla, J., Corral-Benavides, S. A., González‐González, J. G., & Tamez-Pérez, H. E. (2015) · Pancreas · doi:10.1097/mpa.0000000000000300 · Cited by 15
Saleh, M. A., Mansoor, E., & Cooper, G. S. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i40.7332 · Cited by 16
Reper, P., Attou, R., Gucciardo, L., Gottignies, P., Devriendt, J., & Massaut, J. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.04.018 · Cited by 15
Mszar, R., Bart, S., Sakers, A. P., Soffer, D. E., & Karalis, D. G. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041382 · Cited by 17
“For individuals with pre-existing HTG, excess alcohol consumption can lead to a substantial increase in TG levels and an increased risk of AP [37].”
BackgroundPancreatitis in Hyperlipemic Mink ( Mustela vison )
Nordstoga, K., Sørby, R., Olivecrona, G., Smith, A. J., & Christophersen, B. O. (2011) · Veterinary Pathology · doi:10.1177/0300985811417248 · Cited by 13
“It is thought that an excess of free fatty acids plays an important role,(3,21) but the exact physiological mechanisms are not well explained.(9) Hyperlipoproteinemia type I is a human condition associated with a deficiency of lipoprotein lipase (LPL), which leads to severe hyperlipoproteinemia and pancreatitis.”
BackgroundHypertriglyceridemic pancreatitis in pregnancy: case reports and review of the literature
Thulasidass, K., & Chowdhury, T. A. (2013) · JRSM Short Reports · doi:10.1177/2042533313481211 · Cited by 12
“Hypertriglyceridemia is a well-recognized cause of pancreatitis.(3) The exact mechanism by which triglycerides induce pancreatitis is unclear, but it is thought that high levels of triglycerides are hydrolysed in the pancreatic vascular bed, leading to high free fatty acid levels, which induce inflammatory changes and…”
BackgroundTey, T. T., Maung, A. C., Lim, K. W., & Hsiang, J. C. (2019) · ACG Case Reports Journal · doi:10.14309/crj.0000000000000025 · Cited by 12
“These free fatty acids then aggregate to form micellar structures with detergent properties that damage the vascular endothelium and acinar cells producing ischemia.(7) The risk of pancreatitis increases by 4% for every 100 mg/dL increase in triglyceride concentration.”
BackgroundFitts, E. C., Lee, P., & Yates, S. G. (2019) · Transfusion · doi:10.1111/trf.15532 · Cited by 14
Qureshi, T. M., Khan, A., Javaid, H., Tabash, A., Hussein, M. S., & Othman, M. O. (2021) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2021.01.005 · Cited by 13
Hypertriglyceridemic pancreatitis: perspectives from China
Fan, Z., Li, J., & Wu, D. (2025) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000001123 · Cited by 11
Effects of eicosapentaenoic acid and docosahexaenoic acid on lipoproteins in hypertriglyceridemia
Patel, A., & Budoff, M. J. (2016) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000233 · Cited by 12
“com triglyceride levels (200–499 mg/dl), treatment is recommended to reduce CVD risk [20].”
BackgroundMorkos, M., Amblee, A. P., Henriquez, A., Basu, S., & Fogelfeld, L. A. (2019) · Endocrine Practice · doi:10.4158/ep-2018-0599 · Cited by 11
“HTG is a frequently silent disease with several possible etiologies including genetic (like lipoprotein lipase deficiency and apolipoprotein CII deficiency), plurigenetic, and secondary disorders (such as obesity, diabetes, alcohol, pregnancy, and certain medications) (4-6).”
Zhang, Q., Fu, Z., Li, S., Ding, X., Zhang, W., Ma, R., & Zhai, Q. (2023) · Pancreatology · doi:10.1016/j.pan.2023.10.023 · Cited by 11
Ai, J., He, W., Huang, X., Wu, Y., Lei, Y., Chen, Y., Görgülü, K., Diakopoulos, K. N., Lü, N., & Zhu, Y. (2020) · Medicine · doi:10.1097/md.0000000000022644 · Cited by 11
“HTG is a well-known cause of AP, accounting for approximately 10% to 19% of all cases.([14,15]) Hyperlipidemia can be”
BackgroundManagement of hypertriglyceridaemia-induced acute pancreatitis in pregnancy
Amin, T., Poon, L. C., Teoh, T. G., Moorthy, K., Robinson, S., Neary, N. M., & Valabhji, J. (2014) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2014.939064 · Cited by 11
“Niacin, also known as nicotinic acid and vitamin B3, reduces triglyceride levels by reducing VLDL secretion [3,20].”
BackgroundInfluentialYang, J., Wu, B. Y., Sha, X., Lu, H., Pan, L., Gu, Y., & Dong, X. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112363 · Cited by 10
Acute pancreatitis secondary to tamoxifen-associated hypertriglyceridemia: A clinical update
Goraya, M. H. N., Abbasi, E. U. H., Amin, M. K., Inayat, F., Ashraf, M. J., Qayyum, M., Hussain, N., Nawaz, G., Zaman, M. A., & Malik, A. (2022) · Journal of Oncology Pharmacy Practice · doi:10.1177/10781552221093969 · Cited by 10
“The increased levels of triglycerides are hydrolyzed by pancreatic lipases to free fatty acids, which have inflammatory properties leading to inflammation of the pancreas.(26) We performed a thorough review of the published literature for reported cases of tamoxifen-related hypertriglyceridemic pancreatitis.”
BackgroundKoopal, C., Bemelmans, R. H. H., Marais, A. D., & Visseren, F. L. J. (2019) · BMJ Case Reports · doi:10.1136/bcr-2018-228199 · Cited by 10
Gonzales, K. M., Donato, L. J., Shah, P., & Simha, V. (2020) · Journal of clinical lipidology · doi:10.1016/j.jacl.2020.11.010 · Cited by 12
Wu, Y., Xin, J., Loehrer, E. A., Jiang, X., Yuan, Q., Christiani, D. C., Shi, H., Liu, L., Li, S., Wang, M., et al. (2022) · European Journal of Clinical Nutrition · doi:10.1038/s41430-022-01078-6 · Cited by 10
“On the other hand, high serum TG levels can also result in impaired blood flow, ischemia and inflammation by increasing plasma viscosity [58, 59].”
Backgroundd-Dimer Change in Human Acute Pancreatitis as Determined by Serumal Triglyceride
Kong, H., Ding, Z., Zhu, X.-C., Gao, X.-Y., Wu, J., Qian, W., Wang, C.-Y., & Hou, X. (2011) · Pancreas · doi:10.1097/mpa.0b013e3182204ae3 · Cited by 10
Jung, H., Ji, Y., Kim, N., Kim, D.-Y., Kim, K., & Choi, B.-H. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/7312472 · Cited by 10
Zheng, H., Wang, D., Wang, X., Lin, Y., Lu, Z., Chen, Y., Feng, G., & Yang, N. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01383-8 · Cited by 9
Sevastru, S., Wakatsuki, M., Fennell, J., & Grocott, M. P. W. (2012) · BMJ Case Reports · doi:10.1136/bcr.11.2011.5208 · Cited by 9
Therapeutic plasma exchange in hypertriglyceridemic patients
Şimşir, İ. Y., Soyaltın, U. E., Yürekli, B. Ş., Erdoğan, M., Çetinkalp, Ş., Saygılı, F., Dönmez, A., & Özgen, G. (2019) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1811-105 · Cited by 9
“In HTG, TGs are destroyed by pancreatic lipases, which cause the release of free fatty acids and subsequent lipotoxicity, leading to chemical pancreatitis [4].”
BackgroundInfluentialHuang, Z., Yu, S.-H., Liang, H., Zhou, J., Yan, H., Chen, T., Cheng, L., Ning, L., Wang, T., Luo, Z., et al. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0276-6 · Cited by 9
“In addition, triglycerides (TG), which can be transformed into to FFA, have been reported to have a mildto-moderate elevated level in plasma (2-10 mmol/L) in approximately half of the patients with AP [9].”
Copeland, L. A., Swendsen, C. S., Sears, D. M., MacCarthy, A. A., & McNeal, C. J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0179998 · Cited by 10
Attia, H., Alzoubi, A., Alanazi, N. H. A. B. M., Alshanwani, A. R., El-Orabi, N. F., Alanteet, A. A., Mohamad, R. A., & Ali, R. (2023) · Toxicological Research · doi:10.1007/s43188-023-00198-w · Cited by 8
Kim, A. S., Hakeem, R., Abdullah, A., Hooper, A. J., Tchan, M. C., Alahakoon, T. I., & Girgis, C. M. (2020) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-19-0165 · Cited by 8
Wilson, D. P., Williams, L. H., & Kavey, R.-E. W. (2021) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2021.12.017 · Cited by 11
Avşar, A. F., Yıldırım, M., & Çinkaya, A. (2014) · International Journal of Surgery Case Reports · doi:10.1016/j.ijscr.2014.10.075 · Cited by 8
Tamoxifen-induced acute pancreatitis – a
Czyżykowski, R. Ł., Połowinczak-Przybyłek, J., Janiak, A., Herman, J., & Potemski, P. (2014) · Menopause Review/Przegląd Menopauzalny · doi:10.5114/pm.2014.41089 · Cited by 8
“Another theory suggests that pancreatic lipase hydrolyses an excess of TG to free fatty acids that induce inflammatory changes [2].”
BackgroundSevere Hypertriglyceridemia Associated With Everolimus Treatment After Heart Transplantation
Lo, P., Kearney, K. L., Muir, C. A., Song, N., Eisman, J. A., & Macdonald, P. S. (2020) · AACE Clinical Case Reports · doi:10.4158/accr-2020-0191 · Cited by 7
“Treatment modalities can include insulin, heparin, and/or apheresis in addition to standard lipid lowering agents such as statins, fibrates and others (10).”
BackgroundProtective role of thymoquinone in hyperlipidemia-induced liver injury in LDL-R−/−mice
Wang, F., Yao, W., Yu, D., Hao, Y., Wu, Y., & Zhang, X. (2023) · BMC Gastroenterology · doi:10.1186/s12876-023-02895-0 · Cited by 7
Çelik, M. Y., Canda, E. E., Yazıcı, H., Erdem, F., Yanbolu, A. Y., Altınok, Y. A., Parıltay, E., Akın, H., Uçar, S. K., & Çöker, M. (2024) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2024.02.006 · Cited by 7
Drug treatment of dyslipidemia
Kim, S. (2016) · Journal of Korean Medical Association · doi:10.5124/jkma.2016.59.5.366 · Cited by 7
“당뇨병이 있는 경우 혈당을 엄격하게 조절하는 것이 도움이 되며, 드물게 중성지방이 매우 높아 약물 치료에 충 분하게 반응하지 않아서 빠르게 감소시켜야 할 경우 성분채 집술을 할 수 있다[9].”
Hypertriglyceridemic pancreatitis: epidemiology, pathophysiology and clinical management
de Pretis, N., Amodio, A., & Frulloni, L. (2019) · Herald of Pancreatic Club · doi:10.33149/vkp.2019.01.02 · Cited by 8
Heparanase in Acute Pancreatitis
Khamaysi, I. N., Hamo‐Giladi, D. B., & Abassi, Z. A. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-34521-1_29 · Cited by 7
Hypertriglyceridemia, a causal risk factor for atherosclerosis, and its laboratory assessment
Wieczorek, E., Ćwiklińska, A., & Jankowski, M. (2022) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2022-0189 · Cited by 8
Management of severe hypertriglyceridaemia
Cybulska, B., & Kłosiewicz−Latoszek, L. (2013) · Kardiologia Polska · doi:10.5603/kp.2013.0254 · Cited by 7
“Drug treatment of severe hypertriglyceridaemia (modified from references [8, 23, 24])”
Delayed diagnosis and treatment of extreme hypertriglyceridemia due to rejection of a lipemic sample
Elslande, J. V., Langlois, M. R., Vermeersch, P., Frans, G., der Schueren, B. V., Mertens, A. C., Meijers, B. K. I., Vusser, K. D., & Hijjit, S. (2021) · Biochemia Medica · doi:10.11613/bm.2021.021002 · Cited by 7
“The risk to develop acute pancreatitis rises with increasing TG concentrations, although the severity of pancreatitis does not appear to correlate with TG concentration (18).”
Background‘A lipaemic mystery’: a patient with hypertriglyceridaemic pancreatitis and cerebral infarction
King, P., Smith, P. J., Betteridge, J. D., & Brown, M. (2011) · BMJ Case Reports · doi:10.1136/bcr.09.2011.4819 · Cited by 6
Persistent Hemolysis in a Patient with Pancreatitis
Cook, S. L., & Bruns, D. E. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2011.167452 · Cited by 6
Acute Pancreatitis Secondary to Pembrolizumab-Induced Hypertriglyceridemia
Ashfaq, A. A., Thalambedu, N., & Atiq, M. U. (2023) · Cureus · doi:10.7759/cureus.38315 · Cited by 6
“It is a protein molecule located in the capillary endothelial cells that help in the transport of the enzyme lipoprotein lipase (LPL) produced from adipocyte to the vascular lumen where it breaks down triglycerides into free fatty acids.”
BackgroundInfluentialFamilial hypertriglyceridemia in pregnancy
Hill, A. J., Pacheco, L. D., Saade, G. R., & Hankins, G. D. V. (2014) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2013.11.004 · Cited by 6
Triglycerides and Cardiovascular Disease : A Scientific Statement From the
Pennathur, S., Kris‐Etherton, P. M., Lennie, T. A., Levi, M., Mazzone, T., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Stone, N. J., Ballantyne, C. M., et al. (2011) · Cited by 6
Genetically Engineered Hamster Models of Dyslipidemia and Atherosclerosis
Xian, X., Wang, Y., & Liu, G. E. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-1924-7_26 · Cited by 7
Kella, D., Shoukat, S., & Sperling, L. S. (2012) · Journal of clinical lipidology · doi:10.1016/j.jacl.2012.01.003 · Cited by 6
Triglyceride levels, pancreatitis and choice of lipid-modifying therapy
Preiss, D. (2013) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.12.79 · Cited by 6
Triglycerides: A Sensitizer but Not a Trigger for Hypertriglyceridemic Acute Pancreatitis
Wang, L., Ren, Y., Xu, T., Geng, J., Yang, N., & Wang, R. (2024) · Digestive Diseases and Sciences · doi:10.1007/s10620-024-08412-x · Cited by 5
“Currently, serum TG > 11.3 mmol/L was used as the diagnostic standard for HTG-AP [10].”
InfluentialWadström, B. N., Wulff, A. B., Pedersen, K. M., & Nordestgaard, B. G. (2026) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2026.120772 · Cited by 5
Broder, M. S., Chang, E. Y., Villa, K. F., & Wong, N. D. (2025) · Journal of clinical lipidology · doi:10.1016/j.jacl.2025.08.017 · Cited by 6
The use of heparin in the treatment of acute pancreatitis
Trzaskoma, A., Kruczek, M., Rawski, B., Poniewierka, E., & Kempiński, R. (2013) · Polish Journal of Surgery · doi:10.2478/pjs-2013-0035 · Cited by 5
Yu, B., He, W., He, C., Li, N., Li, J., Zhu, Y., Chen, Y., & Lü, N. (2020) · Pancreas · doi:10.1097/mpa.0000000000001697 · Cited by 5
RetractedHadarits, F., Kisfali, P., Mohás, M., Maász, A., Sümegi, K., Szabó, M. Z., Hetyési, K., Kovács-Valasek, A., Janicsek, I., Wittmann, I., et al. (2010) · Pathology & Oncology Research · doi:10.1007/s12253-010-9273-7 · Cited by 5
“HTG exacerbates the risk for pancreatitis, coronary artery disease and other vascular diseases [3–5].”
BackgroundSouza, C. L., Oliveira, M. V., & Andrade, N. N. N. (2016) · Jornal Brasileiro de Patologia e Medicina Laboratorial · doi:10.5935/1676-2444.20160022 · Cited by 5
“TG levels above 1,000 mg/dl have been proposed as sufficient to induce AP((11)), however it is an arbitrary criterion, since AP may occur at higher or lower levels((1)).”
BackgroundSevere hypertriglyceridemia, acute pancreatitis and chyloptysis
Kalra, S. S., Innabi, A., Runnstrom, M. C., Lascano, J. E., & Patel, D. C. (2019) · QJM · doi:10.1093/qjmed/hcz236 · Cited by 5
Ma, J., Wan, X., Liu, J., Hu, X., Ma, Y., & Gao, Y. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1583889 · Cited by 6
Jang, Y. H., & Kim, H. J. (2019) · The Korean Journal of Pancreas and Biliary Tract · doi:10.15279/kpba.2019.24.3.111 · Cited by 4
Su, W., Gao, Y., Wang, X., Wang, D., Feng, B., Wu, Y., Zheng, H., & Guo, F. (2023) · Scientific Reports · doi:10.1038/s41598-023-40287-2 · Cited by 4
“…that the therapeutic effect of DFPP treatment is based on the immediate physical extracorporeal elimination of TG-rich lipoproteins from plasma, subsequently reducing other patho-physiological processes of pancreatitis, such as inflammation, oxidative stress, and impaired rheology 4,5,12–14 .”
Hypertriglyceridemia-induced acute pancreatitis in pregnancy associated with CREB3L3 mutation
Gurevitz, C., Mechanick, J. I., Do, R., & Rosenson, R. S. (2024) · Journal of clinical lipidology · doi:10.1016/j.jacl.2024.10.001 · Cited by 4
Hypertriglyceride Induced Acute Pancreatitis
Lebenson, J., & Oliver, T. (2012) · InTech eBooks · doi:10.5772/25581 · Cited by 4
Park, K., Yoon, H.-J., Imm, J., & Go, G. (2018) · Journal of Medicinal Food · doi:10.1089/jmf.2018.4224 · Cited by 4
An Interesting Case of Hypertriglyceridaemic Pancreatitis
Anupama Pujar, K. (2013) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2013/5500.3080 · Cited by 4
“2013 June, Vol-7(6): 1169-1171 1170 The severity and complication rates with hypertiglyceridaemic pancreatitis have been reported to be higher as compared to those of acute pancreatitis which occurs due to other aetiologies [7, 8].”
BackgroundChoice of medical therapy to lower triglycerides in those at risk of pancreatitis
Preiss, D., & Sattar, N. A. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000029 · Cited by 4
Pancreatitis Secondary to Dyslipidemia: An Understudied Condition
Jacobs, T. H., Wayne, C. D., Sajankila, N., & Narayanan, S. (2024) · Lipidology · doi:10.3390/lipidology1020009 · Cited by 3
“HTG has been linked to several etiologies, including modifiable factors such as diet and amount of exercise, as well as heritable and genetic conditions such as familial dysbe-talipoproteinemia and FCS [112,113].”
A foray into Understanding the Next Billion Search Users
Gupta, N., & Rosé, C. P. (2009) · Cited by 3
Jaafar, B., Chaaya, J. A., Ammar, S., & Salti, I. (2023) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2023.12 · Cited by 3
A case of acute pancreatitis induced by hypertriglyceridemia in gestational diabetes
Kim, G.-H., Jun, H. A., Song, J. E., Lee, K.-Y., & Kim, S. S. (2010) · Korean Journal of Obstetrics & Gynecology · doi:10.5468/kjog.2010.53.6.535 · Cited by 3
Treatment Targets in the Management of Dyslipidemias: Which Targets in Whom?
Grundy, S. M. (2012) · Current Cardiology Reports · doi:10.1007/s11886-012-0305-7 · Cited by 4
“These latter levels carry risk for acute pancreatitis, especially when triglycerides exceed 1,000 mg/dL [61].”
BackgroundHypertriglyceridaemia: Aetiology, Complications and Management
Blom, D. J. (2010) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/22201009.2010.10872218 · Cited by 3
Hypertriglyceridaemia: Aetiology, complications and management
Blom, D. J. (2010) · South African Family Practice · doi:10.1080/20786204.2010.10873948 · Cited by 3
Nordestgaard, B. G., & Varbo, A. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-56514-5_8 · Cited by 4
Metadata
- Authors
- Ewald, N., Hardt, P. D., & Kloer, H.-U.
- Affiliations
- Universitätsklinikum Gießen und Marburg (DE)
- Corresponding author
- Ewald, Nils
- Venue
- Current Opinion in Lipidology
- Published
- 2009-12
- Volume
- 20
- Issue
- 6
- Pages
- 497-504
- ISSN
- 0957-9672 (ISSN-L)
- OpenAlex
- W2009619895
- Cited by
- 273
- References
- 84
- Citations by year
- 2026: 12 · 2025: 7 · 2024: 16 · 2023: 17 · 2022: 11 · 2021: 16 · 2020: 22 · 2019: 17 · 2018: 15 · 2017: 9 · 2016: 23 · 2015: 17 · 2014: 20 · 2013: 24 · 2012: 15
- FWCI
- 2.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Lipidology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Gastroenterology › Gallbladder and Bile Duct Disorders
- Keywords
- hypertriglyceridemia-induced pancreatitis, severe hypertriglyceridemia, acute pancreatitis, lipoprotein metabolism disorders, pancreatic lipase, free fatty acids, apheresis, insulin therapy, heparin, lipid-lowering drugs, dietary change, chronic pancreatitis, pregnancy
- MeSH terms
- Fatty Acids, Humans, Hydrolysis, Lipase, Lipoproteins, Pancreatitis, Triglycerides, Hypertriglyceridemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.